Literature DB >> 19956062

Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.

Sofia Asioli1, Lori A Erickson, Thomas J Sebo, Jun Zhang, Long Jin, Geoffrey B Thompson, Ricardo V Lloyd.   

Abstract

Papillary thyroid carcinomas (PTC) are the most common thyroid tumors that usually have a good prognosis. Recurrence, metastases, and cancer death may occur in a few patients and are more commonly associated with more aggressive tumors, such as tall cell, columnar cell, or diffuse sclerosing variants of the PTC. We present the clinicopathologic, immunohistochemical, and molecular features of a rare aggressive variant of the PTC showing prominent hobnail features. The patients included 6 females and 2 males. Ages ranged from 28 to 78 years (mean 57.6). Patients presented with a neck mass and cervical lymphadenopathy. Tumor size ranged from 1.0 cm to 4.0 cm (mean 2.5 cm). The tumors were usually multifocal with variably sized complex papillary structures lined by cells with increased nuclear/cytoplasmatic ratios and apically placed nuclei that produced a surface bulge (hobnail appearance). Thyroglobulin, TTF-1, HBME-1, and p53 were positive in all cases, and there was membrane staining for beta-catenin and E-cadherin. The proliferative index with Ki67 ranged from 2% to 20% with a mean of 10%. BRAF mutation was present in 4/7 (57.1%) cases. Distant metastases to liver, lung, bone, brain, muscle, and pancreas developed in 5 patients. The average follow-up time was 77.2 months. Four patients died of disease after a mean of 42.8 months. Two patients are alive with disease after 4 and 87 months, respectively. Two patients are alive without disease after 120 and 236 months. PTC with a prominent hobnail pattern is a moderately differentiated PTC variant with aggressive clinical behavior and significant mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19956062     DOI: 10.1097/PAS.0b013e3181c46677

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  38 in total

Review 1.  Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma.

Authors:  Tyler Janovitz; Justine A Barletta
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

2.  Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.

Authors:  Alyaksandr V Nikitski; Susan L Rominski; Vincenzo Condello; Cihan Kaya; Mamta Wankhede; Federica Panebianco; Hong Yang; Daniel L Altschuler; Yuri E Nikiforov
Journal:  Thyroid       Date:  2019-08-16       Impact factor: 6.568

3.  Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile.

Authors:  Carrie C Lubitz; Konstantinos P Economopoulos; Amanda C Pawlak; Kerry Lynch; Dora Dias-Santagata; William C Faquin; Peter M Sadow
Journal:  Thyroid       Date:  2014-03-06       Impact factor: 6.568

Review 4.  The micropapillary/hobnail variant of papillary thyroid carcinoma: A review of series described in the literature compared to a series from one southern Italy pathology institution.

Authors:  Antonio Ieni; Valeria Barresi; Roberta Cardia; Luana Licata; Flavia Di Bari; Salvatore Benvenga; Giovanni Tuccari
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

Review 5.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 6.  Papillary thyroid carcinoma variants.

Authors:  Ricardo V Lloyd; Darya Buehler; Elham Khanafshar
Journal:  Head Neck Pathol       Date:  2011-01-08

7.  Brain metastases from papillary thyroid carcinomas.

Authors:  Farnaz C Tahmasebi; Peter Farmer; Suzanne Z Powell; Kenneth D Aldape; Gregory N Fuller; Shital Patel; Peter Hollis; David Chalif; Mark B Eisenberg; Jian Yi Li
Journal:  Virchows Arch       Date:  2013-03-27       Impact factor: 4.064

8.  BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.

Authors:  Jason D Prescott; Peter M Sadow; Richard A Hodin; Long Phi Le; Randall D Gaz; Gregory W Randolph; Antonia E Stephen; Sareh Parangi; Gilbert H Daniels; Carrie C Lubitz
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

Review 9.  Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review.

Authors:  Young Sub Lee; Yourha Kim; Sora Jeon; Ja Seong Bae; So Lyung Jung; Chan Kwon Jung
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

10.  Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.

Authors:  Wenwu Dong; Jing Li; Hao Zhang; Yanhong Huang; Liang He; Zhihong Wang; Zhongyan Shan; Weiping Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.